Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 May 9;12(1):7546.
doi: 10.1038/s41598-022-11551-8.

A systematic review and meta-analysis of fusion rate enhancements and bone graft options for spine surgery

Wagner M Tavares  1   2 , Sabrina Araujo de França  3 , Wellingson S Paiva  2 , Manoel J Teixeira  2
Affiliations
Meta-Analysis

A systematic review and meta-analysis of fusion rate enhancements and bone graft options for spine surgery

Wagner M Tavares et al. Sci Rep. .

Abstract

Our study aimed to evaluate differences in outcomes of patients submitted to spinal fusion using different grafts measuring the effectiveness of spinal fusion rates, pseudarthrosis rates, and adverse events. Applying the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, this systematic review and meta-analysis identified 64 eligible articles. The main inclusion criteria were adult patients that were submitted to spinal fusion, autologous iliac crest (AIC), allograft (ALG), alloplastic (ALP; hydroxyapatite, rhBMP-2, rhBMP-7, or the association between them), and local bone (LB), whether in addition to metallic implants or not, was applied. We made a comparison among those groups to evaluate the presence of differences in outcomes, such as fusion rate, hospital stay, follow-up extension (6, 12, 24, and 48 months), pseudarthrosis rate, and adverse events. Sixty-four studies were identified. LB presented significantly higher proportions of fusion rates (95.3% CI 89.7-98.7) compared to the AIC (88.6% CI 84.8-91.9), ALG (87.8% CI 80.8-93.4), and ALP (85.8% CI 75.7-93.5) study groups. Pseudarthrosis presented at a significantly lower pooled proportion of ALG studies (4.8% CI 0.1-15.7) compared to AIC (8.6% CI 4.2-14.2), ALP (7.1% CI 0.9-18.2), and LB (10.3% CI 1.8-24.5). ALP and AIC studies described significantly more cases of adverse events (80 events/404 patients and 860 events/2001 patients, respectively) compared to LB (20 events/311 patients) and ALG (73 events/459 patients). Most studies presented high risk-of-bias scores. Based on fusion rates and adverse events proportions, LB showed a superior trend among the graft cases we analyzed. However, our review revealed highly heterogeneous data and a need for more rigorous studies to better address and assist surgeons' choices of the best spinal grafts.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Local bone pooled proportional rate for spinal fusion.
Figure 2
Figure 2
Autologous iliac crest pooled proportional rate for spinal fusion.
Figure 3
Figure 3
Allograft pooled proportional rate for spinal fusion.
Figure 4
Figure 4
Alloplastic pooled proportional rate for spinal fusion.
See this image and copyright information in PMC

References

    1. Rajaee SS, Bae HW, Kanim LEA, Delamarter RB. Spinal fusion in the United States. Spine (Phila Pa 1976) 2012;37:67–76. doi: 10.1097/BRS.0b013e31820cccfb. - DOI - PubMed
    1. Yoshihara H, Yoneoka D. National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009. Spine J. 2015;15:265–271. doi: 10.1016/j.spinee.2014.09.026. - DOI - PubMed
    1. Associates M, Inc 2014 spinal industry update. Orthop. Netw. News. 2014;25:3–6.
    1. Provaggi E, Capelli C, Leong JJH, Kalaskar DM. A UK-based pilot study of current surgical practice and implant preferences in lumbar fusion surgery. Medicine (Baltimore) 2018;97:e11169. doi: 10.1097/MD.0000000000011169. - DOI - PMC - PubMed
    1. D’Souza M, Macdonald NA, Gendreau JL, et al. Graft materials and biologics for spinal interbody fusion. Biomedicines. 2019;7:75. doi: 10.3390/biomedicines7040075. - DOI - PMC - PubMed